Effect of muramyl peptides on mitochondrial respirationEL-JAMAL, N; BAHR, G. M; ECHTAY, K. S et al.Clinical and experimental immunology (Print). 2009, Vol 155, Num 1, pp 72-78, issn 0009-9104, 7 p.Article

The transcriptional response of human macrophages to murabutide reflects a spectrum of biological effects for the synthetic immunomodulatorGOASDUFF, T; DARCISSAC, E. C. A; VIDAL, V et al.Clinical and experimental immunology (Print). 2002, Vol 128, Num 3, pp 474-482, issn 0009-9104Article

Antibody levels and in vitro lymphoproliferative responses to Streptococcus pyogenes erythrogenic toxin A and mitogen of patients with rheumatic feverBAHR, G. M; ABDUL MOHSEN YOUSOF; KAZEM BEHBEHANI et al.Journal of clinical microbiology (Print). 1991, Vol 29, Num 9, pp 1789-1794, issn 0095-1137Article

Immunotherapy with Mycobacterium vaccae as an adjunct to chemotherapy in the treatment of pulmonary tuberculosisSTANFORD, J. L; BAHR, G. M; BEHBEHANI, K et al.Tubercle. 1990, Vol 71, Num 2, pp 87-93, issn 0041-3879Article

Clinical evaluation of the immunoadjuvant murabutide, a derivative of MDP, administered with a tetanus toxoid vaccineTELZAK, E; WOLFF, S. M; DINARELLO, C. A et al.The Journal of infectious diseases. 1986, Vol 153, Num 3, pp 628-633, issn 0022-1899Article

In vitro inhibition of murine B-cell tumor growth by MDP, MDP(D-D) and Vaccin is mediated by macrophagesLUISA MORAS, M; PHILLIPS, N. C; BAHR, G. M et al.International journal of immunopharmacology. 1985, Vol 7, Num 4, pp 515-524, issn 0192-0561Article

Role of nitric oxide in the regulation of lymphocyte apoptosis and HIV-1 replicationHERMANN, E; IDZIOREK, T; KUSNIERZ, J.-P et al.International journal of immunopharmacology. 1997, Vol 19, Num 7, pp 387-397, issn 0192-0561Article

An enzyme-linked immunosorbent assay using an arc 5 antigen for the diagnosis of cystic hydatid diseaseHIRA, P. R; BAHR, G. M; SHWEIKI, H. M et al.Annals of tropical medicine and parasitology. 1990, Vol 84, Num 2, pp 157-162, issn 0003-4983, 6 p.Article

Adherence of Staphylocuccus epidermidis to pharyngeal epithelial cells mediated by lipoteichoic acidCHUGH, T. D; BAHR, G. M; ESSA, S. A et al.Current microbiology (Print). 1990, Vol 20, Num 5, pp 343-347, issn 0343-8651, 5 p.Article

Mycobacterium vaccae in immunoprophylaxis and immunotherapy of leprosy and tuverculosisSTANFORD, J. L; ROOK, G. A. W; ANSTEY, N et al.Vaccine. 1990, Vol 8, Num 6, pp 525-530, issn 0264-410X, 6 p.Article

In vitro regulation by muramyl dipeptide of interferon production from peripheral blood mononuclear cells of healthy volunteersAL-ATTIYAH, R. J; BAHR, G. M; STRANNEGARD, O et al.International journal of immunopharmacology. 1988, Vol 10, Num 8, pp 931-938, issn 0192-0561Article

Induction, in vivo and in vitro, of macrophage membrane interleukin-1 by adjuvant-active synthetic muramyl peptidesBAHR, G. M; CHEDID, L. A; BEHBEHANI, K et al.Cellular immunology (Print). 1987, Vol 107, Num 2, pp 443-454, issn 0008-8749Article

Mise en évidence d'une structure bactérienne dans deux médiateurs humains: un facteur favorisant le sommeil et une monokine = Evidence for a bacterial structure in two human mediators: a factor favouring sleep and a monokineCHEDID, L; BAHR, G. M; MODABBER, F. Z et al.Comptes rendus des séances de l'Académie des sciences. Série 3, Sciences de la vie. 1983, Vol 297, Num 4, pp 209-212, issn 0249-6313Article

Discordant effects of interleukin-2 on viral and immune parameters in human immunodeficiency virus-1-infected monocyte-derived mature dendritic cellsBAHR, G. M; DARCISSAC, E. C. A; MOUTON, Y et al.Clinical and experimental immunology (Print). 2003, Vol 132, Num 2, pp 289-296, issn 0009-9104, 8 p.Article

Variations in serum IL-7 and 90K/Mac-2 binding protein (Mac-2 BP) levels analysed in cohorts of HIV-1 patients and correlated with clinical changes following antiretroviral therapyDARCISSAC, E. C. A; VIDAL, V; DE LA TRIBONNIERE, X et al.Clinical and experimental immunology (Print). 2001, Vol 126, Num 2, pp 287-294, issn 0009-9104Article

Interleukin-18 modulates immune responses induced by HIV-1 Nef DNA prime/protein boost vaccineBILLAUT-MULOT, O; IDZIOREK, T; BAN, E et al.Vaccine. 2000, Vol 19, Num 1, pp 95-102, issn 0264-410XArticle

Selective modulation of lipopolysaccharide-induced death and cytokine production by various muramyl peptidesPARANT, M. A; POUILLART, P; LE CONTEL, C et al.Infection and immunity. 1995, Vol 63, Num 1, pp 110-115, issn 0019-9567Article

Selection of a muramyl peptide based on its lack of activation of nuclear factor-κB as a potential adjuvant for AIDS vaccinesSHRECK, R; BEVEC, D; DUKOR, P et al.Clinical and experimental immunology (Print). 1992, Vol 90, Num 2, pp 188-193, issn 0009-9104Article

Diagnostic value of anti-arc 5 IgG antibody and analysis of the IgG subclasses in sera of patients with cystic hydatid diseaseHIRA, P. R; BAHR, G. M; SHWEIKI, H. M et al.Serodiagnosis and immunotherapy in infectious disease. 1990, Vol 4, Num 4, pp 285-293, issn 0888-0786, 9 p.Article

Antibody levels to mycobacteria in relation to HLA type: evidence for non-HLA-linked high levels of antibody to the 65 kD heat shock protein of M. bovis in rheumatoid arthritisBAHR, G. M; ROOK, G. A. W; AL-SAFFAR, M et al.Clinical and experimental immunology (Print). 1988, Vol 74, Num 2, pp 211-215, issn 0009-9104, 5 p.Article

In vivo effects of ovalbumin-conjugated muramyl peptides on the anti-ovalbumin IgE and IgG responses in micePROUVOST-DANON, A; BAHR, G. M; CHEDID, L et al.International journal of immunopharmacology. 1984, Vol 6, Num 5, pp 425-431, issn 0192-0561Article

Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progressionAMIEL, C; DARCISSAC, E; TRUONG, M.-J et al.The Journal of infectious diseases. 1999, Vol 179, Num 1, pp 83-91, issn 0022-1899Article

Recombinant human IL-16 inhibits HIV-1 replication and protects against activation-induced cell death (AICD)IDZIOREK, T; KHALIFE, J; BILLAUT-MULOT, O et al.Clinical and experimental immunology (Print). 1998, Vol 112, Num 1, pp 84-91, issn 0009-9104Article

Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activationRUHL, M; HIMMELSPACH, M; HAUBER, J et al.The Journal of cell biology. 1993, Vol 123, Num 6, pp 1309-1320, issn 0021-9525, 1Article

Analysis of the in vitro lymphoproliferative responses and antibody levels to the arc-5 antigen in patients with cystic hydatid diseaseSHWEIKI, H. M; BAHR, G. M; SALAMA, M. S et al.Annals of tropical medicine and parasitology. 1992, Vol 86, Num 6, pp 621-629, issn 0003-4983Article